Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John P. Butler Insider Profile
11 Followers
John P. Butler, CEO & President, Director at Akebia Therapeutics, holds 2.36M shares in Akebia Therapeutics (Ticker: AKBA), holds 0.00 shares in Zynerba Pharmaceuticals (Ticker: ZYNE), holds 10.00K shares in Keryx Biopharma (Ticker: KERX). Most recently, John P. Butler Sold ― shares of Akebia Therapeutics on Mar 01, 2024 for an estimated value of 73.58K.
John P. Butler Akebia Therapeutics (AKBA)CEO & President, Director
Akebia Therapeutics (AKBA)
CEO & President, Director
Ranked #8,341 out of 98,624 Corporate Insiders
Profitable Transactions
11 out of 18 Profitable Transactions
Average Return
+12.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO & President, Director
Roles that John P. Butler holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 05, 2019 - Jun 05, 2020
Return:+174.80%
The most profitable trade made by John P. Butler
John P. Butler's Trading History
Akebia Therapeutics
Mar 01, 2024
CEO & President, Director
Informative Sell
73.58K
$2.93M
Keryx Biopharma
Jun 20, 2017
―
Uninformative Buy
―
$33.60K
Zynerba Pharmaceuticals
Oct 11, 2023
―
Uninformative Sell
―
$0.00
Relypsa Inc
Jun 23, 2016
―
Uninformative Buy
―
$123.55K
List of latest transactions for each holding click on a transaction to see John P. Butler's performance on stock
You May Also Like
John P. Butler insider profile FAQ
What is the percentage of profitable transactions made by John P. Butler?
The percentage of profitable transactions made by John P. Butler is 61%.
What is the average return per transaction made by John P. Butler?
The average return per transaction made by John P. Butler is 12.90%.
What stocks does John P. Butler hold?
John P. Butler holds: AKBA, KERX, ZYNE, RLYP stocks.
What was John P. Butler’s latest transaction?
John P. Butler latest transaction was an Informative Sell of $73.58K.
What was John P. Butler's most profitable transaction?
John P. Butler’s most profitable transaction was an Informative Buy of AKBA stock on June 5, 2019. The return on the trade was 174.80%.
What is John P. Butler's role in Akebia Therapeutics?
John P. Butler's role in Akebia Therapeutics is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.